These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis. Silvestre-Roig C; Fernández P; Mansego ML; van Tiel CM; Viana R; Anselmi CV; Condorelli G; de Winter RJ; Martín-Fuentes P; Solanas-Barca M; Civeira F; Focaccio A; de Vries CJ; Chaves FJ; Andrés V Circ Cardiovasc Genet; 2014 Feb; 7(1):59-70. PubMed ID: 24395923 [TBL] [Abstract][Full Text] [Related]
25. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. West NE; Ruygrok PN; Disco CM; Webster MW; Lindeboom WK; O'Neill WW; Mercado NF; Serruys PW Circulation; 2004 Feb; 109(7):867-73. PubMed ID: 14757691 [TBL] [Abstract][Full Text] [Related]
26. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329 [TBL] [Abstract][Full Text] [Related]
27. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211 [TBL] [Abstract][Full Text] [Related]
28. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis. Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572 [TBL] [Abstract][Full Text] [Related]
29. The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. Ozben B; Diz-Kucukkaya R; Bilge AK; Hancer VS; Oncul A J Thromb Thrombolysis; 2007 Jun; 23(3):181-7. PubMed ID: 17221329 [TBL] [Abstract][Full Text] [Related]
30. The MHC2TA gene polymorphisms are not associated with restenosis after coronary stenting in Mexican patients. Delgadillo H; Vargas-Alarcón G; Gómez-Monterrosas O; Martínez-Rodríguez N; Ramírez-Fuentes S; Carrillo-Sánchez S; Peña-Duque MA; Martínez-Ríos MA; Pérez-Méndez O; Fragoso JM Arch Cardiol Mex; 2012; 82(3):208-13. PubMed ID: 23021357 [TBL] [Abstract][Full Text] [Related]
31. Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: a case-control study of a Chinese Han population. Shi H; Yu X; Li Q; Ye X; Gao Y; Ma J; Cheng J; Lu Y; Du W; Du J; Ye Q; Zhao X; Zhou L Arch Med Res; 2012 Apr; 43(3):233-42. PubMed ID: 22475777 [TBL] [Abstract][Full Text] [Related]
32. Effects of stent length and lesion length on coronary restenosis. Mauri L; O'Malley AJ; Cutlip DE; Ho KK; Popma JJ; Chauhan MS; Baim DS; Cohen DJ; Kuntz RE Am J Cardiol; 2004 Jun; 93(11):1340-6, A5. PubMed ID: 15165911 [TBL] [Abstract][Full Text] [Related]
33. Predictors of recurrent restenosis after coronary stenting: an analysis of 197 patients. Kishi K; Hiasa Y; Suzuki N; Takahashi T; Hosokawa S; Tanimoto M; Otani R J Invasive Cardiol; 2002 Apr; 14(4):187-91. PubMed ID: 11923572 [TBL] [Abstract][Full Text] [Related]
34. Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries. Koch W; Ndrepepa G; Mehilli J; Braun S; Burghartz M; Lengnick H; Kölling K; Schömig A; Kastrati A Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2229-34. PubMed ID: 14604831 [TBL] [Abstract][Full Text] [Related]
35. Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting. Dudek D; Heba G; Giszterowicz D; Rzeszutko Ł; Legutko J; Bartuś S; Chyrchel M; Dubiel JS Kardiol Pol; 2006 Sep; 64(9):929-36; discussion 937-8. PubMed ID: 17054024 [TBL] [Abstract][Full Text] [Related]
36. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569 [TBL] [Abstract][Full Text] [Related]
37. No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. Hoppmann P; Erl A; Türk S; Tiroch K; Mehilli J; Schömig A; Kastrati A; Koch W JACC Cardiovasc Interv; 2009 Nov; 2(11):1149-55. PubMed ID: 19926059 [TBL] [Abstract][Full Text] [Related]
38. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma. Koytak ES; Mizrak D; Bektaş M; Verdi H; Arslan Ergül A; Idilman R; Cinar K; Yurdaydin C; Ersõz S; Karayalçin K; Uzunalimoğlu O; Bozkaya H Turk J Gastroenterol; 2008 Dec; 19(4):245-9. PubMed ID: 19119483 [TBL] [Abstract][Full Text] [Related]
39. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941 [TBL] [Abstract][Full Text] [Related]
40. Candidate genetic markers and the risk of restenosis after coronary angioplasty. Völzke H; Grimm R; Robinson DM; Wolff B; Schwahn C; Hertwig S; Motz W; Rettig R Clin Sci (Lond); 2004 Jan; 106(1):35-42. PubMed ID: 12899665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]